Close Menu
  • Home
  • Browse Issues
    • In Press
    • Current Issue
    • Past Issues
  • About
    • Journal
    • Aim and Scope
    • Editorial Board
    • Bibliographic Listings
    • Editorial Policy
      • Publication Ethics
      • Peer Review Policy
      • Open Access Policy
      • Copyright Policy
      • Plagiarism Policy
      • Retraction Policy
      • Terms and Conditions
    • Disclaimer
  • Author Guidelines
  • Submit Article
  • Downloads
  • Contact Us
What's New

Dual Nephroprotective Strategy of Dapagliflozin and Telmisartan in the Management of Diabetic Kidney Disease: A Comprehensive Review

Pharmacological Approaches in Alcohol Use Disorder-Exploring Off-Label an Emerging Treatments in Clinical and Preclinical Evidence

Artificial Intelligence in Hemovigilance: Advancing Blood Safety and Monitoring Systems

Facebook X (Twitter) Instagram
  • Home
  • Author Guidelines
  • Factsheet
  • Contact
Journal of Young Pharmacists
Author Guidelines Submit Article
  • Home
  • Browse Issues
    • In Press
    • Current Issue
    • Past Issues
  • About
    • Journal
    • Aim and Scope
    • Editorial Board
    • Bibliographic Listings
    • Editorial Policy
      • Publication Ethics
      • Peer Review Policy
      • Open Access Policy
      • Copyright Policy
      • Plagiarism Policy
      • Retraction Policy
      • Terms and Conditions
    • Disclaimer
  • Author Guidelines
  • Submit Article
  • Downloads
  • Contact Us
Journal of Young Pharmacists

Disclaimer

Disclaimer

Journal of Young Pharmacists (JYP) provides this and other forums for the presentation of diverse opinions and positions by scientists worldwide, regardless of their race, citizenship, gender, religion, or political viewpoint. The views presented in this publication do not reflect the official positions of the parent organization.

JYP is not liable for any errors or omissions in the content of the articles published on this site. Despite the fact that JYP has taken every precaution to ensure the accuracy of the content, we cannot accept responsibility. In articles contributed by our contributing authors, views may not necessarily reflect those of the editorial team or owners of JYP.

Editor's Picks
Latest Articles

Dual Nephroprotective Strategy of Dapagliflozin and Telmisartan in the Management of Diabetic Kidney Disease: A Comprehensive Review

November 8, 2025

Pharmacological Approaches in Alcohol Use Disorder-Exploring Off-Label an Emerging Treatments in Clinical and Preclinical Evidence

November 8, 2025

Artificial Intelligence in Hemovigilance: Advancing Blood Safety and Monitoring Systems

November 8, 2025
About
About

The Journal of Young Pharmacists (JYP) [p-ISSN -0975-1483 ;e-ISSN- 0975-1505] is a peer-reviewed journal and is a leading source of information on developments and trends in pharmacy education, practice, and research.

Facebook X (Twitter)
Important Links
  • Home
  • Editorial Board
  • Author Guidelines
  • Past Issues
Resources
  • Open Access Policy
  • Publication Ethics
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • Contact Us

Subscribe to Updates

Get the latest TOC from J Young Pharm.

© 2025, Journal of Young Pharmacists. All Rights Reserved. | Powered by Manuscript TechnoMedia LLP.
  • Home
  • Editorial Board
  • Author Guidelines
  • Past Issues

Type above and press Enter to search. Press Esc to cancel.